Abstract

ObjectiveRituximab (RTX) treatment results in B cell depletion in rheumatoid arthritis (RA), however, clinical responses to RTX may differ. In this study, the authors wished to assess the efficacy and...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call